These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15368885)

  • 1. Management of renal anaemia: comparison of practice in the Czech Republic and Northern England.
    Lindley E; Pancírová J; Kraciková J; Lopot F; Green D; Harrington M; De Vos JY; Elseviers M;
    EDTNA ERCA J; 2004; 30(2):75-83. PubMed ID: 15368885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of renal anemia with erythropoietin].
    Spustova V; Kovac A
    Bratisl Lek Listy; 1999 Aug; 100(8):432-8. PubMed ID: 10645031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

  • 5. Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously.
    Macdougall IC; Hutton RD; Cavill I; Coles GA; Williams JD
    BMJ; 1989 Jul; 299(6692):157-8. PubMed ID: 2504356
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
    Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
    Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPD: using evidence based clinical practice guidelines in the management of anaemia in patients with chronic renal failure.
    Price L; Osborne S
    Collegian; 2003 Jan; 10(1):35-7. PubMed ID: 15481510
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron.
    Silverberg DS; Wexler D; Blum M; Tchebiner JZ; Sheps D; Keren G; Schwartz D; Baruch R; Yachnin T; Shaked M; Schwartz I; Steinbruch S; Iaina A
    Nephrol Dial Transplant; 2003 Jan; 18(1):141-6. PubMed ID: 12480972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional implications of recombinant human erythropoietin therapy in renal disease.
    Sanders HN; Rabb HA; Bittle P; Ramirez G
    J Am Diet Assoc; 1994 Sep; 94(9):1023-9. PubMed ID: 8071484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee.
    Schröder CH;
    Pediatr Nephrol; 2003 Aug; 18(8):805-9. PubMed ID: 12750985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.
    Goicoechea M; Vazquez MI; Ruiz MA; Gomez-Campdera F; Perez-García R; Valderrábano F
    Nephron; 1998; 78(1):23-7. PubMed ID: 9453399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of anaemia in renal failure.
    Macdougall I
    EDTNA ERCA J; 1999; 25(1):19-22. PubMed ID: 10418372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of the anaemia of chronic renal failure with recombinant human erythropoietin.
    Winearls CG
    Drugs; 1989 Sep; 38(3):342-5. PubMed ID: 2806134
    [No Abstract]   [Full Text] [Related]  

  • 15. European Practice Database in the Czech Republic.
    Pancírová J; Kraciková J; Lopot F; De Vos JY; Elseviers M
    EDTNA ERCA J; 2004; 30(2):71-4. PubMed ID: 15368884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin (rHuEPO) in the treatment of anaemia of chronic renal failure.
    Desai JD; Shah BV
    J Assoc Physicians India; 1991 Jun; 39(6):483-5. PubMed ID: 1938855
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyporesponsiveness to recombinant human erythropoietin.
    Drüeke T
    Nephrol Dial Transplant; 2001; 16 Suppl 7():25-8. PubMed ID: 11590253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintenance hemodialysis patients.
    Tarng DC; Chen TW; Huang TP
    Am J Nephrol; 1995; 15(3):230-7. PubMed ID: 7618648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anemia and renal failure: efficacy of its control].
    Fort J
    Nefrologia; 2006; 26 Suppl 3():28-32. PubMed ID: 17469424
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of the anemia of chronic renal failure with recombinant human erythropoietin.
    Adamson JW; Eschbach JW
    Annu Rev Med; 1990; 41():349-60. PubMed ID: 2184735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.